Patenting Risk Evaluation & Mitigation Strategies; For Pharmaceuticals: A New Life Cycle Management Target for Patents?
02 January 2009
Foley Partners Stephen Maebius, Judith Waltz, David Rosen and Associate Sean Tu authored an article titled “Patenting Risk Evaluation & Mitigation Strategies; For Pharmaceuticals: A New Life Cycle Management Target for Patents?” in the January 2, 2009 issue of BNA’s Pharmaceutical Law & Industry Report.
Reproduced with permission from BNA’s Pharmaceutical Law & Industry Report, by The Bureau of National Affairs, Inc. http://www.bna.com.
Author(s)
Related Insights
18 March 2025
Energy Current
Mexican Government Proposes Bill to Regulate the Energy Sector
On February 4, 2025, Mexican President Claudia Sheinbaum submitted a bill to the Mexican Senate to revoke, issue, and amend various energy laws in accordance with the constitutional amendments passed in December 2024.
18 March 2025
Innovative Technology Insights
The Symbiotic Future of Quantum Computing and AI
While quantum computers remain in their infancy, AI could provide a bridge to unlocking their potential.
18 March 2025
Foley Viewpoints
Amendments to the Amparo Law
On March 13, 2025, several amendments to the Amparo Law were published. These amendments intend to harmonize the Amparo Law with the recent modifications made to the structure and operation of the Federal Judicial System.